In The Object of Interpretation, Professor Urbina offers a comprehensive exploration of this topic. He addresses the nature of the object
The push for greater clinical trial transparency is typically framed as a conflict between companies’ interest in protecting trade secrets and the public’s interest in accessing health-relevant information. But a new article by economists Dennis Byrski and Lucy Xiaolu Wang
Health law does not have the luxury of standing still. Scientific advances, clinical practice changes, and entirely new technological possibilities are on the horizon. Technology, Health and Law in Life and Death is a collection edited by Dr. Neera Bhatia
As a person of a certain age, I’ve attended my fair share of dinner parties hosted by parents of young children. More times
As feminist scholars have long observed, the rise of populist governance has often been fueled by the enforcement of rigid gender and family roles. Populist leaders frequently cast themselves as the guardians of traditional gender norms and family structures
When NFL star Colin Kaepernick was in the spotlight in 2016 for protesting police violence, the notion of “defund the police” was just a fledgling idea in criminal justice reform. At that time, he aligned with and amplified the Black
Diversity, equity, and inclusion (DEI) efforts at the board level and beyond have been a major topic in corporate governance for the last decade or two. Those efforts have mainly focused on gender and racial diversity, but initiatives (now struck
When corporations make commitments to stakeholders, they often do so voluntarily and without contracts. But perhaps unsurprisingly, they also regularly flip-flop on those voluntary commitments.Take retailer Target. A few years ago, it rolled out a variety of initiatives aimed at
Non-statutory review, ultra vires review, and Leedom v. Kyne, the leading case on non-statutory review, all have one thing in common—when I come across them, my eyes glaze over, and I pretend it never happened, hoping they will all go
